Survey of the Deficits in Surgeons’ Knowledge of Contralateral Prophylactic Mastectomy | Breast Cancer | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Rosenberg  SM, Tracy  MS, Meyer  ME,  et al.  Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.  Ann Intern Med. 2013;159(6):373-381.PubMedGoogle ScholarCrossref
Portschy  PR, Abbott  AM, Burke  EE,  et al.  Perceptions of contralateral breast cancer risk: a prospective, longitudinal study.  Ann Surg Oncol. 2015;22(12):3846-3852. PubMedGoogle ScholarCrossref
Mavaddat  N, Peock  S, Frost  D,  et al; EMBRACE.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.  J Natl Cancer Inst. 2013;105(11):812-822.PubMedGoogle ScholarCrossref
Kruper  L, Kauffmann  RM, Smith  DD, Nelson  RA.  Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.  Ann Surg Oncol. 2014;21(11):3448-3456.PubMedGoogle ScholarCrossref
Nichols  HB, Berrington de González  A, Lacey  JV  Jr, Rosenberg  PS, Anderson  WF.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.  J Clin Oncol. 2011;29(12):1564-1569.PubMedGoogle ScholarCrossref
Musiello  T, Bornhammar  E, Saunders  C.  Breast surgeons’ perceptions and attitudes towards contralateral prophylactic mastectomy.  ANZ J Surg. 2013;83(7-8):527-532.PubMedGoogle ScholarCrossref
Research Letter
April 2016

Survey of the Deficits in Surgeons’ Knowledge of Contralateral Prophylactic Mastectomy

Author Affiliations
  • 1Department of Surgery, NorthShore University HealthSystem, Evanston Hospital, Evanston, Illinois
  • 2University of California, San Francisco, School of Medicine, San Francisco
  • 3Dana Farber Cancer Institute, Boston, Massachusetts
  • 4Department of Surgery, MD Anderson Cancer Center, Houston, Texas
  • 5Center for Biomedical Research Informatics, NorthShore University HealthSystem, Evanston, Illinois
JAMA Surg. 2016;151(4):391-393. doi:10.1001/jamasurg.2015.3601

The contralateral prophylactic mastectomy (CPM) rate has increased dramatically over the past decade. The reasons for this trend are multiple but include patient misperceptions about the risk of contralateral breast cancer (CBC) and how a CPM affects recurrence and survival.1,2 Little is known, however, about surgeons’ knowledge of CPM and CBC and how this informs medical decision making. The literature on these topics is continually evolving, but definitive outcomes data and recommendations for CPM are lacking. Because surgeons are most patients’ preferred source of medical information regarding breast cancer,1 we thought it prudent to examine surgeons’ knowledge of CPM. We hypothesized that surgeons’ knowledge of CPM is variable and represents an opportunity for improved education on the topic.